Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

aTYR Pharma INC

NASDAQ: ATYR · Life Sciences · 7 alerts · CIK 1339970

Share price
$5.24Close, Nov 16
Market cap
$13.4M
Shares outstanding
2.55MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All aTYR Pharma INC filings on SEC EDGAR ↗

7:53 AM ET 8-K
Business Update

aTYR Pharma Business Update

aTyr Pharma reached alignment with the FDA on the protocol for a new Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease. The global study is expected to enroll approximately 372 patients and initiate study-related activities in the fourth quarter of 2026.

Counterparty
FDA
Term
54 weeks

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.